Tag Archives: health

Biomedical R&D in the 21st Century

Dale Edgar

Reflecting back upon my career,  I recognize the importance academic-industry research partnerships played in shaping my philosophy as a scientist and research leader.  Something deeply fulfilling happens when basic and applied scientists ally, and our individual passion to make a difference in the life of a patient merges into a community effort. We are moving ever closer to solving some of the toughest biomedical challenges of our time.  But this is also an era of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

#BIO 2013: Open Innovation and Biopharmaceutical R&D

Menelas Pangalos

In these changing times, the concept of Open Innovation is one that we at AstraZeneca have fully embraced. By sharing new ideas and enabling scientific innovation to cross boundaries between companies, academia, government and non-profit organizations, we can accelerate new ideas into innovative medicines. An Open Innovation discussion at BIO I will discuss the importance that AstraZeneca places on Open Innovation today at this year’s BIO International Convention. An interactive session will include a panel discussion and presentations Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Q & A with Eli Lilly’s Eric Siemers

Q+A with Eli Lillys Eric Siemers

In October 2012, Eli Lilly and Company released results of its Expedition trials, two Phase 3, double-blind, placebo-controlled studies of the anti-amyloid antibody solanezumab, in patients with mild-to-moderate Alzheimer’s disease. Although cognitive decline was slowed in patients with early stage disease in one trial, and there were also positive signs from the other trial, those findings were not statistically significant. But a secondary analysis conducted independently by a panel of academic researchers pooled data from Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

New Challenges in the Fast Changing Landscape of Bioinformatics

Adina

The world of DNA sequencing and bioinformatics has evolved at a staggering pace. In 2009, the biggest problem for researchers was creating an efficient solution for sequencing DNA. At that time, sequencing cost of $100,000 for a single human and took 30 days of chemical processing to produce the raw sequencing output. In four years, DNA sequencing technology has advanced rapidly, outpacing even Moore’s Law. Today, researchers can sequence a whole human genome for about Read More >

Health  |  2 Comments  |  Email This Post
Tags: , , , , , , , , ,

Worldwide Orphan Drug Market to Grow to $127 Billion by 2018

Infographic

The 2013 Orphan Drug Report from Evaluate, which launched today at the 2013 BIO international Convention, sheds light on the market dynamics of orphan drugs — pharmaceutical products aimed at rare diseases or disorders — projecting that sales will experience a compound annual growth rate of 7.4 percent between 2012 and 2018, nearly double that of the prescription drug market, excluding generics.  The report based on EvaluatePharma® data found that the worldwide orphan drug market Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,